Target intelligence / Profile preview

Serine dehydratase (SDS)

Target
SDS
Molecular classification
Enzyme, Pyridoxal phosphate (PLP)-dependent enzyme, Member of the β-family of PLP-dependent enzymes
01

Overview

Serine dehydratase is a pyridoxal phosphate (PLP)-dependent enzyme primarily expressed in the liver, where it catalyzes the deamination of L-serine (and L-threonine) to produce pyruvate (or 2-oxobutyrate) and ammonia[3][5][11]. It is essential for gluconeogenesis from amino acids and thus plays a key role in maintaining glucose homeostasis. Structurally, human serine dehydratase is a homodimer comprised of two domains within each monomer—a large PLP-binding catalytic domain and a small regulatory domain—forming the active site at their interface[3][5]. The enzyme is found in various organisms and its structural properties vary among species, but its catalytic role in amino acid metabolism is highly conserved. Deficient activity of serine dehydratase can contribute to disease states associated with impaired serine and glycine metabolism, and the enzyme attracts interest in metabolic and neurodegenerative disease research. No clinically approved drugs are known to target serine dehydratase directly at this time.

Other names
L-serine dehydrataseL-threonine deaminaseSDHhSDHhepatic serine dehydrataseL-serine deaminaseL-threonine dehydrataseL-serine ammonia-lyaseTDH
02

Mechanism of action

Not applicable (no drugs targeting this enzyme are clinically established); enzyme catalyzes the PLP-dependent deamination of L-serine to pyruvate and ammonia[3][5][11]

03

Biological functions

GluconeogenesisAmino acid catabolismDeamination of L-serine and L-threonine to pyruvate or 2-oxobutyrateRegulation of amino acid pools in liver cytoplasm[3][5][11]
04

Disease associations

Disorders of serine metabolism (including primary serine deficiency)Potential metabolic roles in cancer and neurological disordersDiabetic neuropathy[2][8]
05

Safety considerations

No specific safety or therapeutic challenges documented for direct enzyme targeting; disturbances in serine metabolism may have neurological consequences[2]
06

Biomarkers

L-serine levels (as an indirect biomarker for serine dehydratase activity in studies of serine metabolism and metabolic disorders)[2]

Beyond the preview

Go deeper on Serine dehydratase (SDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine dehydratase (SDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call